Edition:
United States

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

719.55INR
2 Dec 2016
Change (% chg)

Rs-23.60 (-3.18%)
Prev Close
Rs743.15
Open
Rs743.45
Day's High
Rs743.45
Day's Low
Rs717.00
Volume
1,457,782
Avg. Vol
2,235,092
52-wk High
Rs895.00
52-wk Low
Rs582.00

Select another date:

Fri, Nov 25 2016

BRIEF-Aurobindo Pharma unit Arrow Generiques to buy select assets in France from Teva

* Aurobindo Pharma Ltd says Arrow Generiques to acquire select assets in France from Teva

BRIEF-India's Aurobindo Pharma Q2 consol net profit rises 33.5 pct

* Sept quarter consol net profit 6.06 billion rupees Source text for Eikon: http://bit.ly/2fS1r1x Further company coverage: (Reporting by Promit Mukherjee)

Founders of India's Aurobindo Pharma to sell up to $135 mln of shares -term sheet

MUMBAI, Oct 6 The founders of India's Aurobindo Pharma are selling shares worth up to $135 million in a block trade on Friday, according to a deal term sheet seen by Reuters.

BRIEF-Aurobindo Pharma gets USFDA tentative approval for Dolutegravir

* Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the PEPFAR market Source text: (http://bit.ly/2cTnfIs) Further company coverage: (Bengaluru newsroom)

Indian shares edge up but caution prevails ahead of Fed comments

Aug 24 Indian shares closed slightly higher on Wednesday, led by drug maker Aurobindo Pharma Ltd after stellar quarterly results, but sentiment remained edgy as investors awaited further cues on whether the U.S. Federal Reserve will raise interest rates this year.

Indian shares edge up; caution prevails ahead of Yellen speech

Aug 24 Indian shares crept up on Wednesday, led by drug maker Aurobindo Pharma Ltd after stellar quarterly results, but sentiment remained edgy as investors awaited further clues on whether the Federal Reserve will raise U.S. interest rates this year.

Select another date: